Seattle, WA6 Active Studies

Chronic Lymphocytic Leukemia Clinical Trials in Seattle, WA

Find 6 actively recruiting chronic lymphocytic leukemia clinical trials in Seattle, WA. Connect with local research sites and explore new treatment options.

6
Active Trials
4
Sponsors
572
Enrolling

Recruiting Chronic Lymphocytic Leukemia Studies in Seattle

About Chronic Lymphocytic Leukemia Clinical Trials in Seattle

Chronic lymphocytic leukemia (CLL) is a slow-growing cancer of the blood and bone marrow that affects B lymphocytes. It is the most common type of adult leukemia. Treatment options include targeted therapies, chemotherapy, and immunotherapy.

There are currently 6 chronic lymphocytic leukemia clinical trials recruiting participants in Seattle, WA. These studies are seeking a combined 572 participants. Research is being sponsored by BeiGene, Ascentage Pharma Group Inc., VA Office of Research and Development and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Lymphocytic Leukemia Clinical Trials in Seattle — FAQ

Are there chronic lymphocytic leukemia clinical trials in Seattle?

Yes, there are 6 chronic lymphocytic leukemia clinical trials currently recruiting in Seattle, WA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Seattle?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you about next steps.

Are clinical trials in Seattle free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seattle studies also compensate for your time and travel.

What chronic lymphocytic leukemia treatments are being tested?

The 6 active trials in Seattle are testing new therapies including novel drugs, biologics, and treatment approaches for chronic lymphocytic leukemia.

Data updated October 18, 2026 from ClinicalTrials.gov